Sociedad Americana de Hirudoterapia

Primary intracranial choriocarcinoma: a case report

Case report published in Clinical neuropathology (1986)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportEnsayos clínicosBjornsson J et al. · Clinical neuropathology, 1986

Abstract

A 10-year-old girl had a primary choriocarcinoma of the posterior third ventricle. Craniotomy a few hours before death did not yield any tumor tissue. At autopsy, an extensively hemorrhagic tumor abutted the pineal gland. Immunostains were positive for beta-human chorionic gonadotropin (beta-HCG) but were negative for alpha-fetoprotein and carcinoembryonic antigen. The presence of beta-HCG in serum or cerebrospinal fluid may be used as a diagnostic marker and monitor of therapy. HCG is, however, not a unique marker for trophoblastic neoplasms, as a significant number of intracranial germinomas contain cells that are beta-HCG positive. Because of the rarity of primary extragenital choriocarcinomas and the much more common occurrence of metastases of genital choriocarcinomas, it is doubtful whether any investigation less than detailed autopsy can prove the extragenital origin of the tumor.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article
Indexed MeSH termsCerebral Ventricle NeoplasmsChildChoriocarcinomaFemaleGonadotropinsHumansNeoplasms, Unknown PrimaryPregnancyTrophoblastic Neoplasms

Resumen

A 10-year-old girl had a primary choriocarcinoma of the posterior third ventricle.

Por qué esto importa para la hirudoterapia

This case report details a primary intracranial choriocarcinoma of the posterior third ventricle in a 10-year-old girl, focusing on diagnostic markers like beta-human chorionic gonadotropin. The abstract focuses entirely on oncological pathology, autopsy findings, and diagnostic challenges regarding extragenital tumors. There is no mention of leeches, anticoagulation, or related therapies in the provided text. Consequently, this article has no discernible relevance to the American Society of Hirudotherapy, the leech secretome, or related fields.

Citación

Primary intracranial choriocarcinoma: a case report

Bjornsson J et al. · Clinical neuropathology, 1986

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.